Search Results - Scott F Huntington

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis by Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan

    Get full text
    Article


  2. 2

    Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis by Mengyang Di, Jessica B. Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington

    Published in Haematologica (2023-01-01)
    Get full text
    Article


  3. 3

    Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib by Rong Wang, Jessica M. Stempel, Rory M. Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Jan Philipp Bewersdorf, Lourdes Mendez, Xiaomei Ma, Nikolai A. Podoltsev

    Published in Blood Neoplasia (2025-11-01)
    Get full text
    Article


  4. 4

    Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia by Nikolai A. Podoltsev, Rong Wang, Rory M. Shallis, Jessica M. Stempel, Mengyang Di, Natalia Neparidze, Amer M. Zeidan, Scott F. Huntington, Smith Giri, Sarah C. Hull, Steven D. Gore, Xiaomei Ma

    Published in Cancer Medicine (2023-09-01)
    Get full text
    Article


  5. 5

    Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy by Scott F. Huntington, Dee Lin, Marie‐Hélène Lafeuille, Philippe Thompson‐Leduc, Aditi Shah, Nina Kim, Laura Hester, Anabelle Tardif‐Samson, Bronwyn Moore, Jessica Fowler, Alexander Marshall, Xinke Zhang, Dina Gifkins, Bingcao Wu

    Published in Pharmacology Research & Perspectives (2024-12-01)
    Get full text
    Article


  6. 6

    Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML by Abdulrahman Alhajahjeh, Kishan K. Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Stuart Seropian, Lohith Gowda, Scott F. Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf

    Published in Blood Advances (2025-10-01)
    Get full text
    Article


  7. 7

    Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study by Joseph S Ross, Molly Moore Jeffery, Lee Jones, Jessica D Ritchie, Cary P Gross, Jonas Paludo, Matthew Diamond, Vishal Bhatnagar, Amylou C Dueck, Kathryn J Ruddy, Gita Thanarajasingam, Abbie Brown, Elizabeth Cathcart-Rake, Louis Faust, Mallorie H Fiero, Brad Powers, Paul G Kluetz, Scott F Huntington, Brie N Noble, Sarah E Schellhorn, Michelle E Tarver

    Published in BMJ Open (2024-01-01)
    Get full text
    Article


  8. 8

    Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers by Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Qualls, Behzad Amoozgar, Brad Kahl, John Baird, Pavan Challa, Scott F Huntington, Jennifer Santos, Steven Bair, Mayur Narkhede, Shuning Li, Zachary Frosch, Carrie Ho, Stephen D Smith, Allison Winter, Daniel Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Mwanasha Merril, Jennifer L. Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla, Emily C Ayers

    Published in Haematologica (2024-11-01)
    Get full text
    Article


Search Tools: